World's Best Scientists 2026 revealed!
Giampietro Corradin

Giampietro Corradin

D-Index & Metrics

Immunology

D-Index
71
Citations
16080
World Ranking
2344
National Ranking
61

Giampietro Corradin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Giampietro Corradin sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 291 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Giampietro Corradin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Giampietro Corradin sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Giampietro Corradin is affiliated with the University of Lausanne in Switzerland and has contributed extensively to the field of Medicine, with a primary focus on Public Health, Environmental and Occupational Health, Infectious Diseases, Immunology, Molecular Biology, and Radiology, Nuclear Medicine and Imaging. Their research encompasses topics related to Malaria Research and Control, Mosquito-borne diseases and control, SARS-CoV-2 and COVID-19 Research, Monoclonal and Polyclonal Antibodies Research, COVID-19 Clinical Research Studies, vaccines and immunoinformatics approaches, as well as Invertebrate Immune Response Mechanisms.

Corradin's body of work includes the following recent papers:

  • Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine, 2022, published in Nature Communications
  • Trimeric SARS-CoV-2 Spike Proteins Produced from CHO Cells in Bioreactors Are High-Quality Antigens, 2020, published in Processes
  • Nanotechnological immunoassay for rapid label-free analysis of candidate malaria vaccines, 2020, published in Nanoscale
  • Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity, 2020, published in Frontiers in Immunology
  • Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems, 2021, published in Frontiers in Immunology

Frequent co-authors collaborating with Corradin include:

  • Myriam Arévalo-Herrera
  • Sócrates Herrera
  • Andrey V. Kajava
  • Florian Μ. Wurm
  • Valentina Agnolon

Corradin's publications have appeared primarily in the following venues:

  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Processes
  • Nanoscale

The range of Corradin's research highlights involvement in clinical trials, vaccine design and evaluation, immunoassays, and protein production methods for infectious diseases such as malaria and viral pathogens. Their interdisciplinary approach integrates molecular biology, immunology, and public health strategies to address challenges in disease control and prevention.

Best Publications

  • Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells

    Paola Panina-Bordignon;Agnes Tan;Annemarie Termijtelen;Stefan Demotz

  • Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

    Pedro Romero;Janet L. Maryanski;Giampietro Corradin;Ruth S. Nussenzweig

  • Lymphocyte Specificity to Protein Antigens: I. Characterization of the Antigen-Induced in Vitro T Cell-Dependent Proliferative Response with Lymph Node Cells from Primed Mice

    Giampietro Corradin;Howard M. Etlinger;Jacques M. Chiller

  • Malarial hemozoin is a Nalp3 inflammasome activating danger signal.

    Catherine Dostert;Greta Guarda;Jackeline F. Romero;Philippe Menu

  • The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host

    Alida Coppi;Ramya Natarajan;Gabriele Pradel;Brandy L. Bennett

  • H—2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide

    Janet L. Maryanski;Pietro Pala;Giampietro Corradin;Bertrand R. Jordan

  • Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres : importance of polymer degradation and antigen release for immune response

    Claudio Thomasin;Giampietro Corradin;Ying Men;Hans P. Merkle

  • Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination.

    D Valmori;A Pessi;E Bianchi;G Corradin

  • A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide.

    Ying Men;Claudio Thomasin;Hans P. Merkle;Bruno Gander

  • A research agenda for malaria eradication: vaccines.

    S. Abdulla;P. Agre;P.L. Alonso;M. Arevalo-Herrera

  • A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein

    Joshua Tan;Joshua Tan;Brandon K Sack;David Oyen;Isabelle Zenklusen;Isabelle Zenklusen

  • Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen

    Régine Audran;Régine Audran;Michel Cachat;Floriana Lurati;Soe Soe

  • Update on the clinical development of candidate malaria vaccines

    W. Ripley Ballou;Myriam Arevalo-Herrera;Daniel Carucci;Thomas L. Richie

  • Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro.

    Régine Audran;Katrin Peter;Jens Dannull;Ying Men

  • A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.

    Pierre Druilhe;François Spertini;Daw Soesoe;Giampietro Corradin

  • Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.

    Pål Johansen;Ying Men;Régine Audran;Giampietro Corradin

  • De novo design of fibrils made of short α-helical coiled coil peptides

    S.A Potekhin;T.N Melnik;V Popov;N.F Lanina

  • The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.

    G Del Giudice;J A Cooper;J Merino;A S Verdini

  • MHC class I- and class II-restricted processing and presentation of microencapsulated antigens

    Ying Men;Régine Audran;Claudio Thomasin;Gérard Eberl

  • Delineation of several DR-restricted tetanus toxin T cell epitopes.

    Stephane Demotz;Antonio Lanzavecchia;Ulrich Eisel;Heiner Niemann

Frequent Co-Authors

François Spertini
François Spertini University Hospital of Lausanne
Myriam Arévalo-Herrera
Myriam Arévalo-Herrera Caucaseco Scientific Research Center
Elisabetta Bianchi
Elisabetta Bianchi Institut Pasteur
Andrey V. Kajava
Andrey V. Kajava University of Montpellier
Nicolas Fasel
Nicolas Fasel University of Lausanne
Pierre Druilhe
Pierre Druilhe Institut Pasteur
Ingrid Felger
Ingrid Felger University of Basel
Bruno Gander
Bruno Gander ETH Zurich
Gérard Eberl
Gérard Eberl Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare roles, many of which require specialized nursing qualifications. For those looking to advance within nursing, pursuing an acute care certification for FNP can be a valuable stepping stone, enabling practitioners to manage complex patient cases effectively.

Many students prefer accelerated programs to enter the workforce quickly. Options like accelerated FNP programs offer intensive training schedules tailored for those who already hold a nursing degree but want to advance rapidly.

Non-nurses interested in healthcare careers can explore foundational nursing education through online ADN programs for non nurses. These flexible programs focus on preparing students for essential nursing roles, laying a strong groundwork in clinical skills.

Additionally, for those seeking a quicker entry point into nursing, some of the easiest ABSN programs to get into provide a streamlined pathway to earning a Bachelor of Science in Nursing. These options help motivated learners transition smoothly into immunology-related healthcare careers.

Best Scientists Citing Giampietro Corradin

Trending Scientists

Recently Published Articles